141 related articles for article (PubMed ID: 35479943)
21. Associations of the
Han Z; Sheng H; Gao Q; Fan Y; Xie X
Biomed Rep; 2021 Jan; 14(1):14. PubMed ID: 33269075
[TBL] [Abstract][Full Text] [Related]
22. Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: A meta-analysis.
Zhang HZ; Wu JH; Huang Q; Yang Q; Sima Q; Chen KY; Li ZR; He GH
J Cosmet Dermatol; 2021 Jul; 20(7):2359-2368. PubMed ID: 33219596
[TBL] [Abstract][Full Text] [Related]
23. Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta-analysis.
Chen XL; Wang YM; Zhao F; Chen Z; Yang X; Sun C; Gao Y; Yang TG; Tian G; Chen YM; Zhu SL; Lin XB; Liu FB
J Gene Med; 2019 Sep; 21(9):e3114. PubMed ID: 31330573
[TBL] [Abstract][Full Text] [Related]
24. PHARMACOGENETIC EFFECTS OF METHOTREXATE (MTX) IN UKRAINIAN PATIENTS DEPENDING ON THE MTHFR GENOTYPES (CLINICAL CASES).
Fedota O; Roschenyuk L; Tyzhnenko T; Merenkova I; Vorontsov V
Georgian Med News; 2018 Jun; (279):111-117. PubMed ID: 30035732
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis.
Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J
JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628
[TBL] [Abstract][Full Text] [Related]
26. Single Nucleotide Polymorphisms in
Gálvez AS; Ramírez H; Placencia P; Rojas C; Urzúa X; Kalergis AM; Salazar LA; Escobar-Vera J
Front Genet; 2021; 12():640956. PubMed ID: 34616421
[TBL] [Abstract][Full Text] [Related]
27.
Huang J; Mei J; Jiang L; Jiang Z; Liu H; Ding F
Biomed Rep; 2014 Mar; 2(2):172-176. PubMed ID: 24649091
[TBL] [Abstract][Full Text] [Related]
28. Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies.
Han J; Liu L; Meng L; Guo H; Zhang J; Han ZQ; Hong ZY
Front Oncol; 2021; 11():759805. PubMed ID: 35004279
[TBL] [Abstract][Full Text] [Related]
29. Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.
Lima A; Bernardes M; Azevedo R; Seabra V; Medeiros R
Pharmacogenomics; 2016 Oct; 17(15):1649-1674. PubMed ID: 27676277
[TBL] [Abstract][Full Text] [Related]
30. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T
Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia.
Esmaili MA; Kazemi A; Faranoush M; Mellstedt H; Zaker F; Safa M; Mehrvar N; Rezvany MR
Iran J Basic Med Sci; 2020 Jun; 23(6):800-809. PubMed ID: 32695297
[TBL] [Abstract][Full Text] [Related]
32. Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.
Świerkot J; Ślęzak R; Karpiński P; Pawłowska J; Noga L; Szechiński J; Wiland P
Pol Arch Med Wewn; 2015; 125(3):152-61. PubMed ID: 25599563
[TBL] [Abstract][Full Text] [Related]
33. Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
El-Khodary NM; El-Haggar SM; Eid MA; Ebeid EN
Med Oncol; 2012 Sep; 29(3):2053-62. PubMed ID: 21644011
[TBL] [Abstract][Full Text] [Related]
34. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
35. Interaction of MTHFR gene with smoking and alcohol use and haplotype combination susceptibility to psoriasis in Chinese population.
Luo Q; Zeng J; Li W; Lin L; Zhou X; Tian X; Liu W; Zhang L; Zhang X
Immunol Res; 2018 Aug; 66(4):543-547. PubMed ID: 30084051
[TBL] [Abstract][Full Text] [Related]
36. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer.
Hagleitner MM; Coenen MJ; Aplenc R; Patiño-Garcia A; Chiusolo P; Gemmati D; De Mattei M; Ongaro A; Krajinovic M; Hoogerbrugge PM; Vermeulen SH; te Loo DM
Pharmacogenomics J; 2014 Apr; 14(2):115-9. PubMed ID: 23648444
[TBL] [Abstract][Full Text] [Related]
37. Unlocking the role of the B7-H4 polymorphism in psoriasis: Insights into methotrexate treatment outcomes: A prospective cohort study.
Wang B; Wang Z; Yang W; Han L; Huang Q; Yawalkar N; Zhang Z; Yao Y; Yan K
Immunology; 2024 Jan; 171(1):104-116. PubMed ID: 37814391
[TBL] [Abstract][Full Text] [Related]
38. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
39. Presence of the methylenetetrahydrofolate reductase gene polymorphism MTHFR C677T in molar tissue but not maternal blood predicts failure of methotrexate treatment for low-risk gestational trophoblastic neoplasia.
Qu J; Usui H; Kaku H; Shozu M
Eur J Pharmacol; 2017 Jan; 794():85-91. PubMed ID: 27840191
[TBL] [Abstract][Full Text] [Related]
40. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.
Busger Op Vollenbroek FTM; Doggen CJM; Janssens RWA; Bernelot Moens HJ
PLoS One; 2018; 13(3):e0194401. PubMed ID: 29570708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
